FDA delays tesamorelin panel

FDA will reschedule a Feb. 24 meeting of the Endocrinologic and Metabolic Drugs Advisory Committee to discuss an NDA from Theratechnologies Inc. (TSX:TH) for tesamorelin due to an administrative delay...